Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial
Top Cited Papers
- 9 January 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 389 (10069), 603-611
- https://doi.org/10.1016/s0140-6736(16)32410-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase III Study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III)International Journal of Stroke, 2013
- The Modified Graeb ScoreStroke, 2013
- Minimally Invasive Surgery Plus Recombinant Tissue-type Plasminogen Activator for Intracerebral Hemorrhage Evacuation Decreases Perihematomal EdemaStroke, 2013
- Factors Affecting Clot Lysis Rates in Patients With Spontaneous Intraventricular HemorrhageStroke, 2012
- Low-Dose Recombinant Tissue-Type Plasminogen Activator Enhances Clot Resolution in Brain HemorrhageStroke, 2011
- Guidelines for the Management of Spontaneous Intracerebral HemorrhageStroke, 2010
- Intraventricular HemorrhageStroke, 2009
- REPRINTCirculation, 2007
- Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trialStatistics in Medicine, 2003
- Better Bootstrap Confidence IntervalsJournal of the American Statistical Association, 1987